Verana Health is introducing the Qdata Thyroid Eye Disease (TED) module, a new database designed with real-world data (RWD) from the American Academy of Ophthalmology (AAO) Intelligent Research in Sight (IRIS) Registry for the clinical study and treatment of TED.
Let’s start with this company.
Verana Health is a San Francisco, California-based digital health software company with a RWD network of 92 million de-identified patients from 20,000+ clinicians (via three data partnerships).
Note: De-identified patient data is data that has had personally identifiable information removed, such as a person’s name, medical history, and test results
Its purpose: to deliver “quality drug lifecycle, medical practice, and medical society insights.”
Who are its data partners?
The three medical registries include:
- AAO IRIS Registry
- 10-year longitudinal database
- American Academy of Neurology Axon Registry
- 6-year longitudinal database
- American Urological Association (AUA) Quality (AQUA) Registry
- 9-year longitudinal database
Gotcha. So what exactly is “Qdata”?
The recently-launched Ophthalmology Qdata is one of three modules offered by Verana, with the other two encompassing neurology and urology.
What they are: an aggregation of “research-ready” data modules.
For ophthalmology: Electronic health record (EHR) data from the IRIS Registry is linked with other data sources (such as ophthalmic images and claims data) to support clinicians’ needs.
Its purpose: to provide research insights and information on entire drug/medical device development life cycles, from clinical trials to commercialization.
What other ophthalmology modules are offered?
Per Verana, Ophthalmology Qdata modules currently available include:
- Anti-vascular endothelial growth factor (VEGF)
- Wet age-related macular degeneration (AMD)
- Dry AMD
- Diabetic retinopathy (DR)
- Diabetic macular edema (DME)
- Geographic atrophy (GA)
- Glaucoma
- Retinal vein occlusion (RVO)
See here for a glimpse of the ophthalmology modules currently in development
Now zero in on this new TED module.
The Qdata module is a curated dataset of RWD from the IRIS Registry of over 250,000 de-identified patients diagnosed with TED.
What it does: provides key insights into TED via diagnostic data extracted from patients’ EHR clinical notes.
What else does it include?
Verana reported that the following key variables will soon be added to the module:
- TED severity designations
- Mild, moderate-to-severe, and sight-threatening
- Clinical Activity Score (CAS)
So what’s the intent of these new insights?
Ideally, this data is intended to assist in “accelerating therapy development, monitoring real-world treatment patterns and outcomes, and informing site selection and patient identification,” according to the company.
Input from the company?
Verana’s CEO Sujay Jadhav noted that, with there being a critical unmet need for focused research and innovative treatment approaches for TED, “real-world evidence can provide a catalyst for breakthroughs in disease management and therapeutic efficacy for this population, which can be challenging to identify.”
Lastly, where can I get a glimpse of this module?
If you’re attending the Innovate TED Symposium in Napa, California, this weekend (April 26-28), you’re in luck!
If not, click here to talk to a Qdata expert.